Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-011099
Filing Date
2017-05-15
Accepted
2017-05-15 17:29:05
Documents
59
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ck0001422142-10q_20170331.htm 10-Q 1588656
2 EX-31.1 ck0001422142-ex311_9.htm EX-31.1 20094
3 EX-31.2 ck0001422142-ex312_8.htm EX-31.2 21331
4 EX-32.1 ck0001422142-ex321_7.htm EX-32.1 10525
5 EX-32.2 ck0001422142-ex322_6.htm EX-32.2 11750
  Complete submission text file 0001564590-17-011099.txt   5254889

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ck0001422142-20170331.xml EX-101.INS 961247
7 XBRL TAXONOMY EXTENSION SCHEMA ck0001422142-20170331.xsd EX-101.SCH 43500
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ck0001422142-20170331_cal.xml EX-101.CAL 33780
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ck0001422142-20170331_def.xml EX-101.DEF 127177
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ck0001422142-20170331_lab.xml EX-101.LAB 335708
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ck0001422142-20170331_pre.xml EX-101.PRE 255501
Mailing Address 9987 CARVER ROAD CINCINNATI OH 45242
Business Address 9987 CARVER ROAD CINCINNATI OH 45242 (513) 985-1920
Aerpio Pharmaceuticals, Inc. (Filer) CIK: 0001422142 (see all company filings)

EIN.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53057 | Film No.: 17846100
SIC: 2834 Pharmaceutical Preparations